ClosedPublished 26 Dec 2023

Revolution Medicines, Inc. /
EQRx, Inc.

Revolution Medicines completed acquisition of EQRx, Inc.

Buy side: Revolution Medicines, Inc.
Buy sideRevolution Medicines, Inc.
Target: EQRx, Inc.
TargetEQRx, Inc.
Source · 26 Dec 2023
Buy side: Revolution Medicines, Inc.
Buy sideRevolution Medicines, Inc.
Target: EQRx, Inc.
TargetEQRx, Inc.
01 / BuyerRevolution Medicines, Inc.
02 / TargetEQRx, Inc.
01

What happened

Revolution Medicines, Inc. completed its acquisition of EQRx, Inc. on Nov. 9, 2023, through a merger. The transaction included the issuance of approximately 54.8 million shares of Revolution Medicines common stock to EQRx stockholders.

The filing says Revolution Medicines primarily acquired EQRx’s cash and marketable securities.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Revolution Medicines completed acquisition of EQRx, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.